文献速递肝病

单等位基因ABHD5突变导致的遗传性非酒精性脂肪性肝病和血脂异常

Inherited non-alcoholic fatty liver disease and dyslipidemia due to monoallelic ABHD5 mutations.
PubMed 文献 · J Hepatol · 2019-04-04

研究对常染色体显性遗传的非酒精性脂肪性肝病患者行全外显子或靶向二代测序,在7个无亲缘关系的多发性家系共39例受累个体中发现单等位基因ABHD5突变相关的可遗传性非酒精性脂肪性肝病和/或血脂异常,临床表型在40岁后完全外显;普通人群中ABHD5相关非酒精性脂肪性肝病患病率估计为1/1137。

要点

  • 单等位基因ABHD5突变可导致常染色体显性遗传的非酒精性脂肪性肝病和/或血脂异常。
  • 7个无亲缘关系多发性家系共39例受累个体,临床表型在40岁后完全表达。
  • 普通人群中ABHD5相关非酒精性脂肪性肝病患病率估计为1/1137。

核心结论

  • 单等位基因ABHD5突变与孟德尔遗传形式的非酒精性脂肪性肝病和/或血脂异常相关。

研究设计与样本

  • 对常染色体显性遗传的非酒精性脂肪性肝病患者行全外显子或靶向二代测序,纳入7个无亲缘关系的多发性家系共39例受累个体。

主要发现

  • 报告了单等位基因ABHD5突变导致的可遗传性非酒精性脂肪性肝病和/或血脂异常,临床表型在40岁后完全表达,见于7个无亲缘关系的多发性家系共39例受累个体。
  • 普通人群中ABHD5相关非酒精性脂肪性肝病患病率估计为1/1137。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Non-alcoholic fatty liver disease (NAFLD) is a multifactorial condition and the most common liver disease worldwide, affecting more than one-third of the population. So far there have been no reports on mendelian inheritance in families with NAFLD. METHODS: We performed whole-exome or targeted next-generation sequencing on patients with autosomal dominant NAFLD. RESULTS: We report a heritable form of NAFLD and/or dyslipidemia due to monoallelic ABHD5 mutations, with complete clinical expression after the fourth decade of life, in 7 unrelated multiplex families encompassing 39 affected individuals. The prevalence of ABHD5-associated NAFLD was estimated to be 1 in 1,137 individuals in a normal population. CONCLUSION: We associate a Mendelian form of NAFLD and/or dyslipidemia with monoallelic ABHD5 mutations. LAY SUMMARY: Non-alcoholic fatty liver disease (NAFLD) is a common multifactorial disorder with a strong genetic component. Inherited forms of NAFLD have been suspected but, their molecular pathogenesis has not been disclosed. Here we report a heritable form of NAFLD with clinical expression after 40 years of age, associated with monoallelic ABHD5 mutations.

来源:J Hepatol,查看原文。版权归原作者所有。

引用

  1. Youssefian L, Vahidnezhad H, Saeidian AH, et al. Inherited non-alcoholic fatty liver disease and dyslipidemia due to monoallelic ABHD5 mutations. J Hepatol. 2019. PMID: 30954460. doi:10.1016/j.jhep.2019.03.026

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。